// App-Quantinova.ai

201 : Perioperative FLOT plus anti-PD-L1 avelumab (FLOT-A) in resectable oesophagogastric adenocarcinoma (OGA): Interim safety analysis results from the ICONIC trial.

Researchers

Presenter

  • Avani Athauda

Principal Investigators

  • Ian Chau

  • David Cunningham

  • David J. Watkins

  • Sheela Rao

  • Eleftheria Kalaitzaki

  • Elli Bourmpaki

  • Michael Davidson

  • Angela Gillbanks

  • Retchel Lazaro-Alcausi

  • Michael Moneypenny

  • Ruwaida Begum

  • Katharina von Loga

  • Isma Rana

  • Pranav Patel

  • Sophie Doran

  • Sacheen Kumar

  • Asif Chaudry

  • Marco Gerlinger

Medical Centers

  • Royal Marsden Hospital, Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden Hospital, Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Translational Oncogenomics Lab, Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Avelumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved